Mythos autonomously exploited vulnerabilities that survived 27 years of human review. Security teams need a new detection playbook

Claude Mythos autonomously found zero-days in OpenBSD, FFmpeg, FreeBSD and major browsers that survived decades of expert ...
pharmaphorum

J&J's Tecvayli claims third national priority FDA approval

Johnson & Johnson's Tecvayli has been approved as part of a combination regimen with its Genmab-partnered Darzalex Faspro as a second-line therapy for relapsed or refractory multiple myeloma, just 55 ...